検索結果 - E. L. Postnova
-
1
Possibility of using mathematical analysis methods to evaluate the potency of antibodies to hepatitis B virus surface antigen in human immunoglobulin preparations
出版事項 2023-10-01全文の入手Scientific relevance. Anti-hepatitis B virus surface-antigen (HBsAg) immunoglobulins are used to prevent hepatitis B in adults and children after exposure and to treat mild to moderate acute viral hepatitis B. The clinical effectiveness of human immunoglobulin preparations is determined by their pot...
論文 -
2
Retrospective Analysis of Viral Hepatitis B Incidence in Russia from 2013 to 2017 in the Context of Preventive Vaccination
出版事項 2018-12-01全文の入手The article presents the results of a retrospective analysis of viral hepatitis B incidence in the Russian Federation from 2013 to 2017, taking into account the use of vaccines included into the National Immunisation Schedule and the Immunisation Programme in Case of Epidemic Outbreaks. The analysis...
論文 -
3
The Use of a Heterologous Anti-Rabies Immunoglobulin for Specific Prevention of Human Rabies
出版事項 2015-10-01全文の入手This paper reviews the problems of passive immunization of rabies. In the Russian Federation remains serious epizoot-epidemiological situation of rabies, characterized the increase of the number of disadvantaged settlements and the registration of the hydrophobia in the population. In these circumst...
論文 -
4
Development, certification, and use of a pharmacopoeial standard for the content of immunoglobulin A in human immunoglobulins for parenteral administration
出版事項 2023-10-01全文の入手Scientific relevance. The immunoglobulin A (IgA) impurity content in parenteral human immunoglobulins should be determined in accordance with the State Pharmacopoeia of the Russian Federation by kinetic nephelometry, radial immunodiffusion, or enzyme immunoassay (ELISA) with a reference standard. Th...
論文 -
5
The stages in standardizing erythropoietin preparations
出版事項 2018-02-01全文の入手Preparations of recombinant human erythropoietin (rhEPO) are included in the list of vital and essential drugs for medical use. When evaluating the quality of EPO preparations during the manufacturing process, under the state marketing authorization and certification procedures, in order to confirm...
論文